Global prevalence of cerebral palsy: A systematic analysis.
Journal
Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
16
06
2022
received:
24
01
2022
accepted:
17
06
2022
pubmed:
12
8
2022
medline:
3
11
2022
entrez:
11
8
2022
Statut:
ppublish
Résumé
To determine trends and current estimates in regional and global prevalence of cerebral palsy (CP). A systematic analysis of data from participating CP registers/surveillance systems and population-based prevalence studies (from birth year 1995) was performed. Quality and risk of bias were assessed for both data sources. Analyses were conducted for pre-/perinatal, postnatal, neonatal, and overall CP. For each region, trends were statistically classified as increasing, decreasing, heterogeneous, or no change, and most recent prevalence estimates with 95% confidence intervals (CI) were calculated. Meta-analyses were conducted to determine current birth prevalence estimates (from birth year 2010). Forty-one regions from 27 countries across five continents were represented. Pre-/perinatal birth prevalence declined significantly across Europe and Australia (11 out of 14 regions), with no change in postneonatal CP. From the limited but increasing data available from regions in low- and middle-income countries (LMICs), birth prevalence for pre-/perinatal CP was as high as 3.4 per 1000 (95% CI 3.0-3.9) live births. Following meta-analyses, birth prevalence for pre-/perinatal CP in regions from high-income countries (HICs) was 1.5 per 1000 (95% CI 1.4-1.6) live births, and 1.6 per 1000 (95% CI 1.5-1.7) live births when postneonatal CP was included. The birth prevalence estimate of CP in HICs declined to 1.6 per 1000 live births. Data available from LMICs indicated markedly higher birth prevalence. • Birth prevalence of pre-/perinatal cerebral palsy (CP) in high-income countries (HICs) is decreasing. • Current overall CP birth prevalence for HICs is 1.6 per 1000 live births. • Trends in low- and middle-income countries (LMICs) cannot currently be measured. • Current birth prevalence in LMICs is markedly higher than in HICs. • Active surveillance of CP helps to assess the impact of medical advancements and social/economic development. • Population-based data on prevalence and trends of CP are critical to inform policy.
Identifiants
pubmed: 35952356
doi: 10.1111/dmcn.15346
pmc: PMC9804547
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1494-1506Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.
Références
Evid Based Ment Health. 2019 Nov;22(4):153-160
pubmed: 31563865
Neuroepidemiology. 2013;40(4):264-8
pubmed: 23363886
Dev Med Child Neurol. 2017 Mar;59(3):317-321
pubmed: 27644438
BMJ Open. 2020 Nov 23;10(11):e038182
pubmed: 33234622
Neuropediatrics. 2020 Apr;51(2):105-112
pubmed: 31910452
Neuroepidemiology. 2012;38(3):138-47
pubmed: 22433124
Semin Pediatr Neurol. 2014 Mar;21(1):30-5
pubmed: 24655402
Dev Med Child Neurol. 2020 Dec;62(12):1414-1422
pubmed: 32686098
Arch Dis Child. 2011 Feb;96(2):180-5
pubmed: 21068077
BMC Pediatr. 2018 Oct 19;18(1):332
pubmed: 30340478
JAMA. 2015 Sep 8;314(10):1039-51
pubmed: 26348753
Dev Med Child Neurol. 2021 Nov;63(11):1327-1336
pubmed: 34031872
Lancet Glob Health. 2021 Dec;9(12):e1654-e1655
pubmed: 34798023
Can J Neurol Sci. 2017 Jul;44(4):366-374
pubmed: 28322177
Health Policy. 2011 May;100(2-3):234-8
pubmed: 20952086
BMC Neurol. 2015 Sep 25;15:173
pubmed: 26407723
Dev Med Child Neurol. 2016 Feb;58 Suppl 2:11-7
pubmed: 26781543
J Rehabil Med. 2018 Dec 25;51(1):47-53
pubmed: 30299526
Brain Dev. 2016 Oct;38(9):792-9
pubmed: 27072917
Arch Dis Child. 2020 Jul;105(7):625-630
pubmed: 31959596
Dev Med Child Neurol. 2022 Dec;64(12):1494-1506
pubmed: 35952356
Dev Med Child Neurol. 2016 Jan;58(1):85-92
pubmed: 26330098
PLoS One. 2014 Jul 14;9(7):e102275
pubmed: 25019202
Dev Med Child Neurol. 2019 Feb;61(2):186-193
pubmed: 30187914
Scott Med J. 2019 Feb;64(1):16-21
pubmed: 30336740
Natl Health Stat Report. 2020 Feb;(139):1-7
pubmed: 32510313
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Lancet Glob Health. 2021 Sep;9(9):e1273-e1285
pubmed: 34358491
Pediatrics. 2016 Jan;137(1):
pubmed: 26659459
Ideggyogy Sz. 2019 Mar 30;72(3-4):115-122
pubmed: 30957466
Brain Dev. 2011 May;33(5):406-11
pubmed: 20797827
Dev Med Child Neurol. 2021 Feb;63(2):156-161
pubmed: 33251607
Arch Dis Child. 2014 Dec;99(12):1103-8
pubmed: 25005523
Dev Med Child Neurol. 2014 Apr;56(4):323-8
pubmed: 24111874
Dev Med Child Neurol. 2013 Jun;55(6):509-19
pubmed: 23346889
J Rehabil Med. 2021 May 24;53(5):jrm00195
pubmed: 33961057
Res Dev Disabil. 2014 Oct 24;36C:207-212
pubmed: 25462481
Pediatr Int. 2021 Aug;63(8):951-957
pubmed: 33176036
Lancet Glob Health. 2017 Dec;5(12):e1275-e1282
pubmed: 29102350
Eur J Paediatr Neurol. 2020 Oct 17;:
pubmed: 34756357
Dev Disabil Res Rev. 2011;17(2):114-29
pubmed: 23362031
Dev Med Child Neurol. 2019 May;61(5):593-600
pubmed: 30417338
Paediatr Perinat Epidemiol. 2016 Sep;30(5):496-510
pubmed: 27215680
Neuropsychiatr Dis Treat. 2014 Jul 08;10:1267-72
pubmed: 25045270
Dev Med Child Neurol. 2019 May;61(5):601-609
pubmed: 30394528
Dev Med Child Neurol. 2016 Feb;58 Suppl 2:25-35
pubmed: 26762733
Eur J Paediatr Neurol. 2018 Sep;22(5):814-821
pubmed: 29779984
J Trop Pediatr. 2011 Aug;57(4):293-5
pubmed: 20889624